Welcome to See King Alpha's Wall Street breakfast, where we cover the top news for investors every morning.

Good morning. Today is Monday, January 8th. I'm Julie Morgan.

Boeing and Spirit Arrow systems are under pressure pre-market following an incident involving

a 737 Max-9. Merck is reportedly in talks to acquire Harpoon therapeutics and Odyssey files for Chapter 11 bankruptcy protection.

Boeing is down 8% pre-market after finding itself back in the spotlight dealing with a safety issue related to one of its plane models.

A so-called door plug on Alaska Airlines flight 1282 blew out on Friday evening causing the cabin to rapidly depressurize.

This happened on a Boeing 737 Max 9 only six minutes after the plane left the Portland International Airport.

The plane landed back in Portland and no serious injuries were reported.

The jetliner was cruising at an altitude of 16,000 feet and no one was sitting in the two seats next to the

affected area. The FAA ordered that certain Boeing 737 Max9 planes be

grounded after the incident.

An investigation is underway to examine the door plug.

Aerospace Supplier Spirit Aerosystems which manufactures and installs the door plugs in question has tumbled more than Boeing in early trading.

16.5% to 26.50 cents a share.

The FAA noted that 171 planes will require inspection before being allowed to return to service.

The part of the plane that blew off has been found in someone's backyard.

Merck is reportedly in advanced talks

to buy immuno oncology company Harpoon Therapeutics

for around $700 million.

Citing people familiar with the matter, Bloomberg News reported on Sunday that Merck

is discussing paying roughly $23 a share for the cancer drug maker.

The offer represents a premium of 118% to Harpoon's last

...